Robert E. Hoffman

Robert E. Hoffman

DirectoratTuHURA Biosciences, Inc./NV· In proxies 2022–2025

Pay in FY2023-63% from the year before · TuHURA Biosciences, Inc./NV stock -97.5% the same year

Robert E. Hoffman was paid $1.2M in FY2023 (Dec), down 63%. TuHURA Biosciences, Inc./NV stock fell 97.5% that year.

Pay$100 in the stock at the end of FY21 → $1
Pay is from the Summary Compensation Table of each TuHURA Biosciences, Inc./NV proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. TuHURA Biosciences, Inc./NVPublic company · 4 yr
    • Director2022 – Present · 4 yrStock in role -100%
  2. Esperion TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  3. FibroGenesisPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. Antibe Therapeutics Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  5. ASLAN Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Aravive, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. CombiMatrix CorporationPublic company
    • Director? – PresentNo stock prices for these years
  8. Compensation Committee of Antibe Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  9. Financial Executives InternationalPublic company
    • Director? – PresentNo stock prices for these years
  10. MabVax Therapeutics Holdings, Inc.Public company
    • Director? – PresentNo stock prices for these years
  11. Saniona ABPublic company · 1 yr
    • Director2021 – 2022 · 1 yrNo stock prices for these years
  12. Kura Oncology, Inc.Public company · 6 yr
    • Director2015 – 2021 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?